From initial medical weight loss with medications like Semaglutide and Tirzepatide, through maintenance support, to final body contouring procedures that complete the transformation process and help patients achieve their ultimate aesthetic goals
A person can absolutely have both, and we need to treat them for both
Overweight individuals aiming for steady, but significant weight loss
Note that the BALANCE demonstration applies to adults with a BMI of 35 or higher, so not all Medicare patients will qualify
No developmental toxicities were observed in rabbits at doses up to 180 mg/kg/day (1191-times the 10 mg clinical dose, based on AUC)
Current research status Retatrutide is currently in Phase 3 clinical trials, with Eli Lilly conducting multiple large-scale studies